Grants and Funding

Elixirgen awarded SBIR Phase I grant

BALTIMORE, August 5, 2016 – Elixirgen has awarded the Small Business Innovation Research (SBIR) Phase I Grant from National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH). The title of the Project: Development of a novel biologic medical product for Dyskeratosis Congenita.